1-7 of 7
E Goluszko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis.

B Wu, C Deng, E Goluszko, P Christadoss
Journal: The Journal of Immunology
J Immunol (1997) 159 (6): 3016–3023.
https://doi.org/10.4049/jimmunol.159.6.3016
Published: 15 September 1997
View article titled, Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis.
Open the PDF for Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. in another window
Add to Citation Manager
Journal Articles

Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.

R Kaul, B Wu, E Goluszko, C Deng, V Dedhia, G H Nabozny, C S David, I J Rimm, M Shenoy, T M Haqqi, P Christadoss
Journal: The Journal of Immunology
J Immunol (1997) 158 (12): 6006–6012.
https://doi.org/10.4049/jimmunol.158.12.6006
Published: 15 June 1997
View article titled, Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
Open the PDF for Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor. in another window
Add to Citation Manager
Journal Articles

IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis.

C Deng, E Goluszko, S Baron, B Wu, P Christadoss
Journal: The Journal of Immunology
J Immunol (1996) 157 (12): 5675–5682.
https://doi.org/10.4049/jimmunol.157.12.5675
Published: 15 December 1996
View article titled, IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis.
Open the PDF for IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis. in another window
Add to Citation Manager
Journal Articles

IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis.

M Shenoy, S Baron, B Wu, E Goluszko, P Christadoss
Journal: The Journal of Immunology
J Immunol (1995) 154 (11): 6203–6208.
https://doi.org/10.4049/jimmunol.154.11.6203
Published: 01 June 1995
View article titled, IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis.
Open the PDF for IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis. in another window
Add to Citation Manager
Journal Articles

TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.

B Wu, M Shenoy, E Goluszko, R Kaul, P Christadoss
Journal: The Journal of Immunology
J Immunol (1995) 154 (7): 3603–3610.
https://doi.org/10.4049/jimmunol.154.7.3603
Published: 01 April 1995
View article titled, TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
Open the PDF for TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains. in another window
Add to Citation Manager
Journal Articles

Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis.

M Shenoy, R Kaul, E Goluszko, C David, P Christadoss
Journal: The Journal of Immunology
J Immunol (1994) 153 (11): 5330–5335.
https://doi.org/10.4049/jimmunol.153.11.5330
Published: 01 December 1994
View article titled, Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis.
Open the PDF for Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis. in another window
Add to Citation Manager
Journal Articles

Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.

R Kaul, M Shenoy, E Goluszko, P Christadoss
Journal: The Journal of Immunology
J Immunol (1994) 152 (6): 3152–3157.
https://doi.org/10.4049/jimmunol.152.6.3152
Published: 15 March 1994
View article titled, Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.
Open the PDF for Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis. in another window
Add to Citation Manager